Highlights from this issue
Exploring the implications of HPV infection for head and neck cancer
Spotting the Signs
Delaying the widespread emergence of cephalosporin-resistant gonorrhoea
Results of a pilot screening programme for genital and extragenital gonococcal and chlamydial infections in a military population following the repeal of ‘Don't Ask, Don't Tell’
Will targeting oropharyngeal gonorrhoea delay the further emergence of drug-resistant Neisseria gonorrhoeae strains?
Will use of combination cephalosporin/azithromycin therapy forestall resistance to cephalosporins in Neisseria gonorrhoeae?
Targeting core groups for gonorrhoea control
Treatment regimens in non-gonococcal urethritis
Imiquimod 5% cream for five consecutive days a week in an HIV-infected observational cohort up to 32 weeks in the treatment of high-grade squamous intraepithelial lesions
Psychological effects of diagnosis and treatment of cervical intraepithelial neoplasia
Engaging young adult clients of community pharmacies for HIV screening in Coastal Kenya
Discordance of HIV and HSV-2 biomarkers and self-reported sexual behaviour among orphan adolescents in Western Kenya
Interest in using rectal microbicides among Australian gay men is associated with perceived HIV vulnerability and engaging in condomless sex with casual partners
Key factors in the acceptability of treatment as prevention (TasP) in Scotland
Associations between rushed condom application and condom use errors and problems
Correlates of a lifetime history of sexually transmitted infections among women who have sex with women in Toronto, Canada
Researching stigmatised communities
Oral human papillomavirus (HPV) infection in men who have sex with men
Frequency and correlates of culture-positive infection with Neisseria gonorrhoeae in England
Anogenital preinvasive and invasive lesions in the Limpopo Province of South Africa
Repeated STI and HIV testing among HIV-negative men who have sex with men attending a large STI clinic in Amsterdam
Survey of the laboratory diagnosis of gonorrhoea and chlamydial infection in the UK
Revised simulation model does not predict rebound in gonorrhoea prevalence where core groups are treated in the presence of antimicrobial resistance
Clinical roundup